Skip to main content
  • Home
  • Gary M. Oderda

Gary M. Oderda

Professor, Director Utah Medicaid Drug Regimen Review Center &; Director, Pharmacotherapy Outcomes Research Center



Gary Oderda received his Pharm. D. degree from the University of California at San Francisco in 1972 and completed an internship and Residency in Clinical Pharmacy at the University of California Hospital in 1973. Additional education was received at the Johns Hopkins University school of Hygiene and Public Health where he received a Masters in Public Health in 1982. In 1991 Dr. Oderda moved to the University of Utah where he serves as a Professor and Chairman of the Department of Pharmacy Practice from 1991 to 1998. On January 1, 1999 Dr. Oderda began a sabbatical from the University of Utah and started as a Visiting Professor in the Department of Health Care Management at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. He was active in a variety of Outcomes Research and Disease Management projects. He returned to the University of Utah on January 1, 2000 where he served as a Professor and Director of the University of Utah Pharmacotherapy Outcomes Research Center. He moved to Emeritus Professor status in 2016 and remains active in consulting and outcomes research and pharmacoeconomics projects.


  • Johns Hopkins University, School of Hygiene and Public Health, MPH (Epidemiology and Biostatistics), 1982

  • University of California Hospital, Residency, 1973

  • University of California San Francisco, PharmD, 1972

Clinical Practice and Research Interests

  • American Association of Poison Control Centers: Data Collection, Personnel Proficiency, Legislative Affairs, Data Access, Annual Meeting, Nominations, Data Access, Bylaws Committees

  • Maryland Academy of Pediatrics Accident Prevention Committee, Consultant, 1980-1991 

  • Technical Advisory Committee on Poison Prevention Packaging, Consumer Product Safety Commission, 1979-1981 

  • USP Advisory Committee on Clinical Toxicology (1990 - 1995) 

  • FDA Advisory Committee on Peripheral and CNS Drugs (1992 - 1995) 

  • American Council on Pharmacy Education Site Visit Team Member. University of Houston (1994, 1996), Western University (1996, 1997) and University of Washington (2002)

Elected Offices

  • Executive Committee, American Association of Poison Control Centers, 1977-1979 and 1979-1981

  • Executive Committee, University of Maryland School of Pharmacy, 1978-1980 

  • Advisory Committee, National Poison Center Network, 1982-1983

  • Secretary-Treasurer, American Association of Poison Control Centers, 1984-1986 

  • Treasurer, American Association of Poison Control Centers, 1986-1988, 1988-1990 

  • President-Elect, American Association of Poison Control Centers, 1990 - 1992 

  • President, American Association of Poison Control Centers, 1992 - 1994 

  • Past President, American Association of Poison Control Centers, 1994 - 1996

Professional Affiliations

  • American Association of Colleges of Pharmacy

  • American Association of Poison Control Centers

  • American College of Clinical Pharmacy (Founding Member)

  • International Society for Pharmacoeconomics and Outcomes Research

  • Kappa Psi

  • Rho Chi

  • Utah Pharmaceutical Association

Courses Taught

  • PCTH 5112 - Profession Of Pharmacy

  • PCTH 6960 - Special Problems in Pharmacotherapy

  • PCTH 6970 - Thesis Research: Masters

  • PCTH 6980 - Faculty Consultation: Masters

  • PCTH 7535 - Advanced International Clerkship

  • PCTH 7538 - Outcomes Clerkship

  • PCTH 7950 - Independent Study

Clinical Practice and Research Interests

  • The major focus of my research program is in Outcomes Research and Pharmacoeconomics with a special interest in pain. This includes the cost of adverse events, cost effectiveness studies involving pharmaceutical products, and the Quality of Life in patients being treated with drugs.

  • A secondary interest is in controlling medication costs and improving drug therapy in Medicaid patients. A current contract with Utah Medicaid is in place to look at these issues